PhAST Corp.
Biotechnology company · Boston, Massachusetts, United States
PhAST Corp. is a biotechnology company headquartered in Boston, Massachusetts, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $600,000 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2025.
PhAST at a glance
What does PhAST do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $600,000 in total (2019). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $3.5 million sold (2025).
Frequently asked questions about PhAST
Where is PhAST headquartered?
PhAST Corp. is headquartered in Boston, Massachusetts, United States.
What does PhAST do?
PhAST Corp. is a biotechnology company.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences